Price of CJ drug readjusted upward

Published: 2011-02-11 06:58:00

Updated: 2011-02-11 06:58:00

The price of CJ’s drug ‘Hepcure’ for the treatment of hepatitis B was readjusted from 3,926 won to 5,197 won per tablet, according to the Ministry of Health and Welfare said.

Currently, innovative drugs see their prices reduced by 20% upon patent expiry and its first-to-market generic version ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK